Inflation and Patent Expirations: Challenges and Opportunities for Pharma in 2024
Key challenges identified by a GlobalData survey include inflation, geopolitical conflict, and drug pricing pressures. Inflation [...]
NIH Working Group Proposes Major Reforms for Postdoctoral Researchers Amid Rising Industry Losses
A National Institutes of Health (NIH) working group proposed significant changes to improve the conditions for [...]
U.S. Health Spending Normalizes Post-Pandemic with a Decrease in GDP Share
The summary of the recent report on U.S. health spending is as follows: Annual Health Spending [...]
Montana’s Slow Utilization of Opioid Settlement Funds Amid Rising Crisis
Nearly a year after Montana received millions of dollars from opioid settlement funds, a significant portion [...]
Gilead Sciences’ Kite Pharma Announces Workforce Reduction and Strategy Shift Amid FDA Review
Gilead Sciences' Kite Pharma is reducing its workforce by approximately 7% as part of a business [...]
NIH Invests $9.7 Million in Research Projects Utilizing All of Us Program Data
The NIH awarded $9.7 million to 26 projects over two years to enhance research using the [...]
Changes in Health Insurance Cost Estimation Could Boost US Inflation Measures
Starting with the October consumer price index, the Bureau of Labor Statistics (BLS) is changing how [...]
Eli Lilly’s Tirzepatide Receives FDA Approval for Obesity Treatment Under Brand Zepbound
Eli Lilly’s drug tirzepatide, branded as Mounjaro for type 2 diabetes, has gained FDA approval to [...]
Biogen Q3 Financials: Stable Revenues, Regulatory Success with Leqembi and Zurzuvae Amid Earnings Dip
Biogen has updated its financial outlook, indicating mixed results in its recent quarterly report. The company [...]
Vertex Pharmaceuticals Misses Q3 Sales Estimates Due to Weak Demand for Older CF Treatments
Vertex Pharmaceuticals missed Wall Street estimates for Q3 sales, primarily due to weaker demand for older [...]
Robust Quarterly Earnings seen for Eli Lilly, Novo Nordisk, Moderna, and Regeneron Amid Success of Key Drugs
Eli Lilly, Novo Nordisk, Moderna, and Regeneron posted solid quarterly earnings due to the success of [...]
Unlocking Patient Safety: Leveraging Real-World Data (RWD) for Drug Development and Care Enhancement
Real-world data (RWD) presents valuable opportunities to enhance patient safety by bridging the gap between research [...]
CDC Recommends Rationing of Sanofi’s Beyfortus Amid Rising RSV Cases and Supply Constraints: Implications for Infant Health Care
Due to supply constraints, the Centers for Disease Control and Prevention (CDC) has recommended rationing of [...]
Forecasted Growth of Real-world Data Market: Role of AI and Big Data in Healthcare Industry and Impact of COVID-19 Pandemic
The Real-world Data (RWD) market is set to grow at a CAGR of 8.2% until 2029, [...]
Zuckerberg’s CZI Invests $250 Million in Advanced Cellular Medicine Project: The New York Biohub
Meta founder Mark Zuckerberg and his wife Priscilla Chan are investing $250 million over ten years [...]
Post-Pandemic Transformation: How Declining COVID-19 Rates are Impacting the Healthcare and Pharma Industries
The healthcare industry is seeing a new transformation as COVID-19 rates decline and the demand for [...]
Optimizing Clinical Trials for Greater Payer Acceptance and Enhanced Patient Access
Biopharma manufacturers face challenges in conveying the clinical value of their medicines to payers due to [...]
Groundbreaking BRAIN Initiative Reveals 3,300 Types of Brain Cells, Offering New Leads for Disease Research and Therapies
Scientists have produced an extensive catalog detailing the types of cells in the human brain and [...]
Recognizing Women’s Contributions in Economics: Claudia Goldin’s Nobel Prize and its Significance
The narrative of economic history has predominantly been recorded through a male viewpoint, with 90 out of 93 Nobel Prizes [...]
Global Real-World Data Market Forecast to Grow at 14.4% CAGR from 2023 to 2030, Fueled by Increased Demand for Evidence-based Medicine and Technological Advancements
The global real-world data (RWD) market, which encompasses data collected outside of clinical trials, is forecasted to grow at a [...]
Cancer Drug Shortages Easing but Still a Challenge, Survey Shows
The issue of cancer drug shortages in the U.S. appears to be easing slightly but persists, according to a survey [...]
American Medical Association Issues Unique PLA Code to Oxford BioDynamics
Oxford BioDynamics PLC has been assigned a unique Proprietary Laboratory Analysis Code (PLA Code) by the American Medical Association's CPT [...]
Trends Projected to Reshape the Healthcare Landscape in 2024
Several societal drivers will shape the healthcare landscape in 2024, including a longer-living population, transformative technologies, and global economic uncertainty. [...]
Novo Nordisk Joins Biopharma Companies Challenging Drug Price Negotiations in Inflation Reduction Act
Novo Nordisk and numerous other biopharma companies are challenging drug price negotiation provisions in the Inflation Reduction Act. Novo has [...]
2023 Nobel Prize in Medicine Awarded to mRNA Researchers Katalin Karikó and Drew Weissman
Katalin Karikó and Drew Weissman, two pioneers of mRNA research, were awarded the 2023 Nobel Prize in Medicine or Physiology [...]